These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 433601)

  • 41. Association of systemic immune complexes, complement activation, and antibodies to Pseudomonas aeruginosa lipopolysaccharide and exotoxin A with mortality in cystic fibrosis.
    Moss RB; Hsu YP; Lewiston NJ; Curd JG; Milgrom H; Hart S; Dyer B; Larrick JW
    Am Rev Respir Dis; 1986 Apr; 133(4):648-52. PubMed ID: 3083745
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interactions of Pseudomonas aeruginosa with immunoglobulins and complement in sputum.
    Hann S; Holsclaw DS
    Infect Immun; 1976 Jul; 14(1):114-7. PubMed ID: 820637
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complement effectors, C5a and C3a, in cystic fibrosis lung fluid correlate with disease severity.
    Hair PS; Sass LA; Vazifedan T; Shah TA; Krishna NK; Cunnion KM
    PLoS One; 2017; 12(3):e0173257. PubMed ID: 28278205
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Precipitating antibodies against E. coli, B. fragilis, and P. aeruginosa in CF patients and normal persons determined by means of crossed immunoelectrophoresis.
    Høiby N; Hertz JB
    Monogr Paediatr; 1979; 10():138-43. PubMed ID: 111037
    [No Abstract]   [Full Text] [Related]  

  • 45. The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa.
    Barth AL; Pitt TL
    J Med Microbiol; 1996 Aug; 45(2):110-9. PubMed ID: 8683546
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Complement factors in gingival crevice material from healthy and inflamed gingiva in humans.
    Attström R; Laurel AB; Lahsson U; Sjöholm A
    J Periodontal Res; 1975 Feb; 10(1):19-27. PubMed ID: 124331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Platelet 3H-serotonin releasing immune complexes induced by Pseudomonas aeruginosa in cystic fibrosis.
    Permin H; Skov PS; Norn S; Høiby N; Schiøtz PO
    Allergy; 1982 Feb; 37(2):93-100. PubMed ID: 7137525
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circulating immune complexes in patients with cystic fibrosis.
    Church JA; Jordan SC; Keens TG; Wang CI
    Chest; 1981 Oct; 80(4):405-11. PubMed ID: 7273892
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response.
    Pedersen SS; Kharazmi A; Espersen F; Høiby N
    Infect Immun; 1990 Oct; 58(10):3363-8. PubMed ID: 2401567
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The precipitins and hypersensitivity reactions in cystic fibrosis.
    McFarlene H; Allan JD; Malhotra A; Hozel A; Wallwork JC
    Compr Ther; 1978 Apr; 4(4):61-7. PubMed ID: 348396
    [No Abstract]   [Full Text] [Related]  

  • 51. Demonstration of neutrophil chemotactic activity in the sputum of cystic fibrosis patients with Pseudomonas aeruginosa infection.
    Kharazmi A; Schiøtz PO; Høiby N; Baek L; Döring G
    Eur J Clin Invest; 1986 Apr; 16(2):143-8. PubMed ID: 3089809
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Th17 associated cytokines in sputum samples from patients with cystic fibrosis.
    Oshalim M; Johansson E; Rabe H; Gilljam M; Lindblad A; Jönsson B
    Pathog Dis; 2020 Sep; 78(6):. PubMed ID: 32876666
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Precipitating antibodies against Haemophilus influenzae and Staphylococcus aureus in sputum and serum from patients with cystic fibrosis.
    Schiøtz PO; Høiby N
    Acta Pathol Microbiol Scand B; 1979 Dec; 87(6):345-51. PubMed ID: 317211
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The chemokine CCL18 characterises Pseudomonas infections in cystic fibrosis lung disease.
    Hector A; Kröner C; Carevic M; Bakele M; Rieber N; Riethmüller J; Griese M; Zissel G; Hartl D
    Eur Respir J; 2014 Dec; 44(6):1608-15. PubMed ID: 25142483
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nitric oxide production by polymorphonuclear leucocytes in infected cystic fibrosis sputum consumes oxygen.
    Kolpen M; Bjarnsholt T; Moser C; Hansen CR; Rickelt LF; Kühl M; Hempel C; Pressler T; Høiby N; Jensen PØ
    Clin Exp Immunol; 2014 Jul; 177(1):310-9. PubMed ID: 24611476
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum complement concentrations, nutritional status and the outcome of measles and measles pneumonia.
    Orren A; Kipps A; Dowdle EB; Shearing S; Falls E
    S Afr Med J; 1979 Mar; 55(14):538-43. PubMed ID: 451781
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Circulating immune complexes, complement activation kinetics and serum sickness following treatment with heterologous anti-snake venom globulin.
    Nielsen H; Sørensen H; Faber V; Svehag SE
    Scand J Immunol; 1978; 7(1):25-33. PubMed ID: 635471
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High levels of complement-activation capacity in sera from patients with cystic fibrosis correlate with high levels of IgG3 antibodies to Pseudomonas aeruginosa antigens and poor lung function.
    Pressler T; Jensen ET; Espersen F; Pedersen SS; Høiby N
    Pediatr Pulmonol; 1995 Aug; 20(2):71-7. PubMed ID: 8570305
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Tuberculosis and cystic fibrosis].
    Friedrichs F; Kusenbach G; Skopnik H
    Klin Padiatr; 1991; 203(5):395-8. PubMed ID: 1942950
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytokines in sputum and serum from patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection as markers of destructive inflammation in the lungs.
    Kronborg G; Hansen MB; Svenson M; Fomsgaard A; Høiby N; Bendtzen K
    Pediatr Pulmonol; 1993 May; 15(5):292-7. PubMed ID: 8327288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.